Guangzhou Leide Bioscience Co., Ltd is an innovative in vitro diagnostic company that focuses on DSCIDS - a new generation of in vitro diagnostic technology. DSCIDS breaks through the limitations of existing molecular diagnostic technology and uses cell function analysis to accurately diagnosis complex immune-mediated diseases.

We have professional team in R&D, production and sales, and we have subsidiary companies in the United States (AIMDX) and Guangzhou (Guangzhou Leide Lab Service Company).

We are honored to be awarded as a "Postdoctoral Innovation Center"; “LeadingTalent Enterprise of Guangdong Province” and “National High-tech Enterprise”.

Our business covers a wide variety fields from infectious diseases, immune function evaluation and immunotherapy for autoimmune diseases to tumors and organ transplants. We have an integrated strategic layout that focuses on the development of in vitro diagnostic reagents, raw materials and special clinical immunoassay services.

It is our mission to research and develop IVD products of immune-mediated diseases to provid high quality products and services that improve human health.

LDEBIO AIMTB Assay Launched

Recently, the AIMTB Assay produced by Guangzhou Leide Biotechnology Co., Ltd. has obtained registration certificates issued by NMPA, and will be officially commercialize in China domestic market

Medlab Middle East 2021

Come visit us at Medlab Middle East 2021


Come visit us at one of the largest annual medical fair MEDICA

Official WeChat
Service hotline:
+86 20 82113921

Add:7D, Science & Technology Innovation Base, #80 Lanyue Road, Huangpu District, Guangzhou, P.R.China

北京理财网站 彩票双色球开奖号是多少 天津11选5前三 三分赛车是正规彩票吗 香港赛马会ccwap15950rg 老快3怎么容易中奖 深圳风采35选7复式 极速赛车微信计划交流群 排列3五行图 上海快3走势图1000 体彩快中彩中奖规则 19年海南环岛赛赛程 创富平特论坛770123 今晚华东15选5开奖号 幸运赛车直播爱彩网 dg品牌官网 亿客隆手机版